TY - JOUR
T1 - Barriers to receipt of prenatal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine among mothers of infants aged <4 months with pertussis — California, 2016
AU - New, Sarah
AU - Winter, Kathleen
AU - Boyte, Rebeca
AU - Harriman, Kathleen
AU - Gutman, Anya
AU - Christiansen, Amber
AU - Royce, Sarah
N1 - Publisher Copyright:
© 2018, Department of Health and Human Services. All Rights Reserved.
PY - 2018/9/28
Y1 - 2018/9/28
N2 - What is already known about this topic? Although tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination is recommended for all pregnant women during 27-36 weeks’ gestation to prevent infant pertussis, coverage among pregnant women is suboptimal. What is added by this report? Among 66 interviewed mothers of infants aged <4 months with pertussis, 30% appropriately received Tdap vaccine. Women whose clinics stocked Tdap vaccine were more likely to be vaccinated. Women with Medicaid were less likely to be vaccinated than were those with private insurance, even when treated in clinics that stocked Tdap vaccine. What are the implications for public health practice? Promoting on-site prenatal vaccination, educating providers about Tdap recommendations, and strengthening off-site referral likely will improve Tdap vaccination coverage during pregnancy.
AB - What is already known about this topic? Although tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination is recommended for all pregnant women during 27-36 weeks’ gestation to prevent infant pertussis, coverage among pregnant women is suboptimal. What is added by this report? Among 66 interviewed mothers of infants aged <4 months with pertussis, 30% appropriately received Tdap vaccine. Women whose clinics stocked Tdap vaccine were more likely to be vaccinated. Women with Medicaid were less likely to be vaccinated than were those with private insurance, even when treated in clinics that stocked Tdap vaccine. What are the implications for public health practice? Promoting on-site prenatal vaccination, educating providers about Tdap recommendations, and strengthening off-site referral likely will improve Tdap vaccination coverage during pregnancy.
UR - http://www.scopus.com/inward/record.url?scp=85054037046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054037046&partnerID=8YFLogxK
U2 - 10.15585/mmwr.mm6738a6
DO - 10.15585/mmwr.mm6738a6
M3 - Article
C2 - 30260942
AN - SCOPUS:85054037046
SN - 0149-2195
VL - 67
SP - 1068
EP - 1071
JO - Morbidity and Mortality Weekly Report
JF - Morbidity and Mortality Weekly Report
IS - 38
ER -